Welcome to the Kim Laboratory

The Kim Laboratory, under the direction of Michelle Kang Kim, MD, PhD is focused largely on assessing outcomes in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) with the purpose of evaluating prognostic factors and optimizing treatments in patients with neuroendocrine tumors. Dr. Kim has completed her PhD in clinical research and throughout her career has had over 40 papers on GEP-NETs published in numerous gastroenterology and oncology journals. Dr. Kim is a current recipient of an American Cancer Society Career Development Award.

Read more.